Position in ZYBT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,618
-$22,600 QoQ
Shares Held
12,730
-61.9% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 8 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYBT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $21,925,909 across 23 Drug Manufacturers - Specialty & Generic names. ZYBT ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
159,508 | $5,530,142 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
55,058 | $4,557,701 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
255,600 | $2,556,000 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
144,816 | $2,506,764 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,292 | $1,241,874 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
22,143 | $908,527 | |
| 7 | PRGO |
PERRIGO Co plc
|
75,700 | $786,523 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
14,800 | $535,760 |
All Filings in ZYBT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,618 | 12,730 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $31,218 | 33,389 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $72,791 | 63,297 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $56,453 | 21,547 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||